Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $189,654 | 85 | 86.5% |
| Travel and Lodging | $22,752 | 18 | 10.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,617 | 2 | 3.0% |
| Food and Beverage | $341.00 | 15 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI PASTEUR INC. | $197,457 | 103 | $0 (2024) |
| Valneva Usa, Inc. | $6,623 | 8 | $0 (2024) |
| Emergent BioSolutions Inc. | $6,323 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $4,095 | 1 | $0 (2024) |
| VBI Vaccines (Delaware) Inc. | $2,125 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,800 | 2 | $0 (2017) |
| VBI Vaccine (Delaware) Inc. | $940.67 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,686 | 4 | AstraZeneca Pharmaceuticals LP ($4,095) |
| 2023 | $2,806 | 4 | Valneva Usa, Inc. ($1,365) |
| 2022 | $9,692 | 11 | Valneva USA, Inc. ($3,992) |
| 2021 | $14,379 | 13 | SANOFI PASTEUR INC. ($8,056) |
| 2020 | $41,323 | 13 | SANOFI PASTEUR INC. ($41,323) |
| 2019 | $28,866 | 13 | SANOFI PASTEUR INC. ($28,866) |
| 2018 | $32,588 | 20 | Sanofi Pasteur Inc. ($32,588) |
| 2017 | $83,024 | 42 | SANOFI PASTEUR INC. ($81,224) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $4,095.00 | General |
| 06/24/2024 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 04/04/2024 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 01/10/2024 | Valneva Usa, Inc. | IXCHIQ (Drug) | Consulting Fee | Cash or cash equivalent | $1,265.83 | General |
| Category: Vaccine | ||||||
| 11/01/2023 | VBI Vaccine (Delaware) Inc. | PreHevbrio (Drug) | Consulting Fee | Cash or cash equivalent | $940.67 | General |
| Category: VACCINES | ||||||
| 08/25/2023 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 07/26/2023 | Valneva Usa, Inc. | — | Consulting Fee | Cash or cash equivalent | $752.50 | General |
| 03/14/2023 | Valneva Usa, Inc. | — | Consulting Fee | Cash or cash equivalent | $612.50 | General |
| 12/27/2022 | Valneva USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $705.83 | General |
| 10/24/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $266.50 | General |
| 09/26/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $1,092.83 | General |
| 09/22/2022 | VBI Vaccines (Delaware) Inc. | PREHEVBRIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: HEPATOLOGY | ||||||
| 09/14/2022 | Valneva USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $486.50 | General |
| 08/17/2022 | Valneva USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $612.50 | General |
| 06/29/2022 | Valneva USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $758.33 | General |
| 06/27/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $188.50 | General |
| 05/23/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $590.67 | General |
| 05/03/2022 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $1,436.00 | General |
| 04/06/2022 | Valneva USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,429.17 | General |
| 12/15/2021 | Emergent BioSolutions Inc. | — | Consulting Fee | Cash or cash equivalent | $2,594.67 | General |
| 11/02/2021 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $60.67 | General |
| 10/12/2021 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $378.00 | General |
| 09/27/2021 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $1,026.67 | General |
| 09/15/2021 | Emergent BioSolutions Inc. | — | Consulting Fee | Cash or cash equivalent | $429.33 | General |
| 08/30/2021 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $527.33 | General |
About Dr. Michael Decker, MD
Dr. Michael Decker, MD is a Infectious Disease healthcare provider based in Baxter, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1710212840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Decker, MD has received a total of $219,364 in payments from pharmaceutical and medical device companies, with $6,686 received in 2024. These payments were reported across 120 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($189,654).
Practice Information
- Specialty Infectious Disease
- Location Baxter, TN
- Active Since 10/07/2009
- Last Updated 04/09/2017
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710212840
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $135,447
- MENACTRA (Drug) $6,763
- PREHEVBRIO (Drug) $2,125
- IXCHIQ (Drug) $1,266
- PreHevbrio (Drug) $940.67
- FLUZONE HIGH-DOSE (Drug) $468.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.